Changyang Gong
- Biomaterials top 0.2%
- Molecular Biology top 5%
- Biomedical Engineering top 1%
- Molecular Medicine top 0.2%
- Immunology top 2%
- Co-authors
- Yuquan WeiQinjie WuZhiyong QianFeng LuoLu SunLei LiuShi HTao He
- Topics
- Nanoplatforms for cancer theranostics (39 papers)RNA Interference and Gene Delivery (38 papers)Nanoparticle-Based Drug Delivery (31 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of the American Chemical SocietyAdvanced Materials
- Partner nations
- ChinaSingaporeUnited States
In The Last Decade
Changyang Gong
156 papers receiving 7.8k citations
Hit Papers
Peers
Comparison fields: 5 of 138
- Biomaterials 2.8k
- Molecular Biology 2.5k
- Biomedical Engineering 2.1k
- Molecular Medicine 1.4k
- Immunology 1.4k
Countries citing papers authored by Changyang Gong
This map shows the geographic impact of Changyang Gong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changyang Gong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changyang Gong more than expected).
Fields of papers citing papers by Changyang Gong
This network shows the impact of papers produced by Changyang Gong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changyang Gong. The network helps show where Changyang Gong may publish in the future.
Co-authorship network of co-authors of Changyang Gong
This figure shows the co-authorship network connecting the top 25 collaborators of Changyang Gong. A scholar is included among the top collaborators of Changyang Gong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changyang Gong. Changyang Gong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 4 | |
| 5 | 6 | |
| 6 | 34 | |
| 7 | 7 | |
| 8 | 1 | |
| 9 | 19 | |
| 10 | 13 | |
| 11 | 15 | |
| 12 | 3 | |
| 13 | 3 | |
| 14 | 5 | |
| 15 | 13 | |
| 16 | 51 | |
| 17 | 7 | |
| 18 | 8 | |
| 19 | A biodegradable hydrogel system containing curcumin encapsulated in micelles for cutaneous wound healingbreakdown → | 457 |
| 20 | 2 |
About Changyang Gong
Changyang Gong is a scholar working on Biomaterials, Molecular Medicine and Rehabilitation, having authored 159 papers that have together received 7.9k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (39 papers), RNA Interference and Gene Delivery (38 papers) and Nanoparticle-Based Drug Delivery (31 papers). The work is most often cited by research in Molecular Medicine (1.4k citations), Biomaterials (2.8k citations) and Pharmaceutical Science (773 citations). Changyang Gong has collaborated with scholars based in China, Singapore and United States. Frequent co-authors include Yuquan Wei, Qinjie Wu, Zhiyong Qian, Feng Luo, Lu Sun, Lei Liu, Shi H, Tao He, Yuwei Zhao and Xiaoze Wang. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Advanced Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.